Chantal Pharmaceutical's cyoctol
Executive Summary
Firm announces IND approval to begin clinicals for cyoctol use in the treatment of male pattern baldness. Initial testing will be conducted at UCLA. Chantal described cyoctol as a synthetic, nonsteroidal anti-androgen that is part of a series of Chantal compounds known as X-Androns. Clinicals are also underway investigating cyoctol use in treatment of acne vulgaris and the company plans to file an IND in 1987 for keloid scar prevention ("The Pink Sheet" Oct. 13, T&G-7).